Pediculosis and phthiriasis

AB1_PEDICULOSIS_AND_PHTHIRIAASIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B85
  • Hospital discharge: ICD-9 — 13[2-3]
  • Hospital discharge: ICD-8 — 13[2-3]
  • Hospital discharge: excluded ICD-9 — 1330A
  • Hospital discharge: excluded ICD-8 — 13[3-4]0
  • Cause of death: ICD-10 — B85
  • Cause of death: ICD-9 — 13[2-3]
  • Cause of death: ICD-8 — 13[2-3]
  • Cause of death: excluded ICD-9 — 1330A
  • Cause of death: excluded ICD-8 — 13[3-4]0

2 out of 7 registries used, show all original rules.

124

4. Check minimum number of events

None

124

5. Include endpoints

None

124

6. Filter based on genotype QC (FinnGen only)

115

Control definitions (FinnGen only)

Control exclude
AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1345 425 908
Only index persons 1108 349 759
Unadjusted period prevalence (%)
Whole population 0.02 0.01 0.03
Only index persons 0.02 0.01 0.03
Median age at first event (years)
Whole population 22.48 24.94 20.92
Only index persons 22.02 24.94 20.68

-FinnGen-

Key figures

All Female Male
Number of individuals 115 37 78
Unadjusted period prevalence (%) 0.03 0.01 0.04
Median age at first event (years) 24.96 31.20 22.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
124
Matched controls
1240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B85.3
ICD-10 Finland
Phthiriasis
+∞
40.9
37
*
B85.0
ICD-10 Finland
Pediculosis due to Pediculus humanus capitis
+∞
23.7
22
*
1322A
ICD-9 Finland
Pediculosis and phthirus infestation, Phthirus pubis [pubic louse]
+∞
21.5
20
*
13299
ICD-8 Finland
Pediculosis
+∞
19.3
18
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
4.3
7.1
20
53
13399
ICD-8 Finland
Acariasis, Other
+∞
6.3
6
*

TimeCodeWAS

↥

TimeCodeWAS is a tool for exploring time-dependent associations between an endpoint and health codes (diagnoses, lab tests, procedures, etc.).

The TimeCodeWAS analysis is done in three steps:

  1. Build a matched case-control set for this endpoint. Each case is matched to 5–10 controls on sex and year of birth, and controls must be at risk at the same age as the case's age of onset. TimeCodeWAS allows for controls to be reused.
  2. Count cases and controls. For each health code, and for each time window: tally the counts into a 2×2 table. To be eligible in a time window, a case or control must have data coverage for at least 50% of that time window.
  3. Perform association tests. If all cells of the 2×2 table have N≥10, then a χ² test is performed, otherwise a Fisher's exact test is done. The corresponding p-value and confidence interval are reported below, along with the standard odds ratio when a χ² test is done, or Fisher's MLE odds ratio otherwise.

TimeCodeWAS currently uses the same default set of time windows for all the endpoints. Please reach out to us if you have suggestions for better time windows for some endpoints. The default time windows are: TimeCodeWAS time windows

Sort & Filter
Sort
Odds Ratio
among windows:
Filter
Code & OMOP
Cases and controls with code
in
Odds Ratio
in
OMOP Concept
Code (OMOP Vocabulary) [OMOP Concept ID]
OMOP Concept Class / OMOP Domain
Odds Ratio
TimeCodeWAS O.R. time legend
Cases and controls with code
TimeCodeWAS Cases and Controls percentages time legend
Case Management Agency
251B00000X (NUCC) [38004193]
Visit / Visit
-1.4e-01 2.9e-01 8.9e-01 3.2e+00 1.7e-01 1.6e-01 3.4e-01
31.51%/34.67% 31.51%/25.66% 20.55%/9.57% 17.81%/0.83% 12.33%/10.58% 27.14%/24.13% 39.39%/31.68%
Pharmacy visit
OMOP4822462 (Visit) [581458]
Visit / Visit
2.4e-02 -1.0e-01 3.5e-01 2.9e+00 5.0e-01 -8.1e-02 -1.8e-01
79.45%/79.06% 64.38%/66.71% 35.62%/28.02% 19.18%/1.25% 42.47%/30.92% 67.14%/68.90% 89.39%/90.99%
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (NUCC) [38003841]
Physician Specialty / Provider
9.6e-01 1.6e+00 — 1.0e+50 — 2.5e+00 1.9e+00
9.59%/3.88% 8.22%/1.80% —/— 68.49%/0.00% —/— 24.29%/2.47% 22.73%/4.19%
betamethasone
S03BA03 (ATC) [21605203]
ATC 5th / Drug
— — — — — — 2.2e+00
—/— —/— —/— —/— —/— —/— 9.09%/1.09%
betamethasone
A07EA04 (ATC) [21600656]
ATC 5th / Drug
9.1e-01 — — — — — 1.6e+00
8.22%/3.47% —/— —/— —/— —/— —/— 13.64%/3.11%
betamethasone
C05AA05 (ATC) [21601610]
ATC 5th / Drug
9.1e-01 — — — — — 1.6e+00
8.22%/3.47% —/— —/— —/— —/— —/— 13.64%/3.11%
betamethasone
D07AC01 (ATC) [21602120]
ATC 5th / Drug
9.1e-01 — — — — — 1.6e+00
8.22%/3.47% —/— —/— —/— —/— —/— 13.64%/3.11%
betamethasone
S02BA07 (ATC) [21605169]
ATC 5th / Drug
9.1e-01 — — — — — 1.6e+00
8.22%/3.47% —/— —/— —/— —/— —/— 13.64%/3.11%
Outpatient Visit
OP (Visit) [9202]
Visit / Visit
-1.8e-02 3.3e-01 -1.2e-01 — 1.5e+00 4.4e-01 6.2e-02
46.58%/47.02% 39.73%/32.18% 6.85%/7.63% —/— 23.29%/6.13% 42.86%/32.56% 57.58%/56.06%

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
57
3.07
3.68
3.7
3.1
24.91
24.40
mmol/l
0.25
16
57
13
48
2.91
2.82
1.2
1.2
—
—
—
0
0
30
166
2.06
2.77
3.1
2.0
—
—
—
0
0
50
345
1.75
2.32
8.1
6.9
—
—
—
0
0
8
24
3.49
2.22
1.1
2.6
51.89
63.69
%
—
8
24
15
69
2.34
2.14
3.6
3.0
—
—
—
0
0
52
376
1.66
1.97
5.8
3.6
6.29
137.45
e6/l
0.96
36
257
5
11
4.69
1.96
1.2
1.5
10.48
11.46
%
—
5
11
20
110
1.98
1.86
1.7
1.8
—
—
—
0
0
38
526
0.60
1.84
3.1
3.0
—
—
—
0
0
40
278
1.65
1.74
5.0
2.8
0.21
0.31
e6/l
0.39
32
198
17
91
2.01
1.70
4.1
7.6
2.14
1.47
mmol/l
0.33
17
91
22
132
1.81
1.59
1.3
1.5
—
—
—
0
0
38
269
1.59
1.52
4.0
2.1
—
—
—
0
0
10
45
2.33
1.51
4.1
3.4
152.60
224.68
mg/l
—
5
19
21
127
1.79
1.48
1.4
1.5
—
—
—
0
0
42
307
1.56
1.46
6.7
6.3
—
—
—
0
0
16
89
1.92
1.45
1.1
1.2
—
—
—
0
0
5
16
3.21
1.45
2.8
2.1
26.24
36.33
%
—
5
16
22
137
1.74
1.41
2.2
1.5
—
—
—
0
0
16
90
1.89
1.41
6.4
8.6
—
—
—
0
0
17
98
1.85
1.39
3.5
4.3
7.36
7.39
ph
—
9
63
12
61
2.07
1.38
4.6
8.6
25.75
24.56
mmol/l
0.44
12
61
44
330
1.52
1.35
3.2
2.4
—
—
—
0
0
18
107
1.80
1.35
4.4
2.1
23.22
31.49
u/l
1.95
18
88
6
24
2.57
1.32
5.0
4.0
3.22
4.47
e9/l
—
6
24
72
600
1.48
1.30
11.0
11.3
3.89
4.20
e9/l
0.70
65
537
43
325
1.49
1.26
4.9
3.0
14.34
37.19
e6/l
1.47
36
242
36
262
1.53
1.26
8.9
4.0
93.36
89.64
%
0.44
36
257
8
37
2.24
1.24
1.5
2.4
—
—
—
0
0
76
648
1.45
1.17
5.3
3.8
—
8.70
—
0
10
41
318
1.43
1.03
5.5
3.8
2.37
2.35
mmol/l
0.31
35
288
23
158
1.56
1.03
3.4
2.8
2.14
1.03
e6/l
0.46
14
75
53
434
1.39
0.98
8.1
5.8
34.40
36.83
g/l
2.08
53
415
16
102
1.65
0.96
3.8
4.3
5.31
5.72
kpa
0.60
16
102
23
161
1.53
0.95
5.1
2.8
2.45
2.43
mmol/l
0.30
18
142
6
31
1.98
0.85
6.0
3.7
56.50
57.31
%
—
6
31
35
275
1.38
0.81
8.2
4.2
—
—
—
0
0
6
33
1.86
0.80
3.5
3.0
7.42
7.41
ph
—
6
33
0
24
0.00
0.80
0.0
1.1
—
5.23
—
0
11
0
24
0.00
0.80
0.0
4.5
—
—
—
0
0
0
27
0.00
0.78
0.0
1.0
—
3.52
—
0
12
27
347
0.72
0.77
3.6
2.7
0.00
0.00
estimate
-0.00
12
87
22
160
1.46
0.77
4.4
2.0
—
—
—
0
0
22
160
1.46
0.77
2.6
2.9
14.74
14.63
umol/l
0.02
22
147
5
24
2.13
0.75
12.6
1.5
—
—
—
0
0
26
335
0.72
0.75
5.5
4.2
6.11
10.27
mg/mmol
0.40
20
220
21
153
1.45
0.73
4.4
2.0
29.81
29.24
s
0.19
21
153
56
480
1.30
0.72
3.6
3.0
6.14
6.09
ph
0.12
28
288
32
253
1.36
0.71
1.2
1.3
1.74
1.51
u/ml
—
8
71
65
570
1.29
0.70
8.4
7.1
0.17
0.19
e9/l
0.56
60
509
7
43
1.66
0.68
7.1
2.5
1.91
1.28
mg/l
—
7
38
5
29
1.75
0.64
3.0
1.9
23.72
24.93
mmol/l
—
5
29
26
326
0.74
0.63
4.2
3.5
44.34
65.15
mg/l
0.29
19
219
0
20
0.00
0.61
0.0
1.5
—
—
—
0
0
20
150
1.40
0.60
6.8
7.0
103.35
104.19
mmol/l
0.56
20
150
103
1081
0.72
0.60
4.7
5.1
1.34
1.38
mmol/l
0.50
97
1030
0
22
0.00
0.60
0.0
1.0
—
4.31
—
0
11
11
73
1.56
0.58
2.6
3.1
70.83
73.71
e9/l
—
6
47
35
289
1.29
0.58
6.8
4.9
7.39
7.40
ph
0.51
28
211
54
472
1.26
0.57
12.2
11.2
0.00
0.00
e9/l
0.50
44
390
39
457
0.79
0.56
4.2
3.0
0.00
0.00
estimate
-0.00
13
93
9
59
1.57
0.56
1.1
2.7
1.31
1.68
%
—
9
59
6
39
1.57
0.54
1.0
1.5
—
205.71
—
0
18
107
1113
0.72
0.53
15.1
12.9
—
—
—
0
0
18
136
1.38
0.53
2.9
2.9
31.08
25.42
%
0.54
18
125
115
1175
0.71
0.52
27.2
21.9
139.82
141.19
g/l
0.41
115
1167
20
155
1.35
0.51
2.3
1.9
—
—
—
0
0
7
45
1.59
0.50
1.1
1.2
—
—
—
0
0
26
211
1.29
0.49
3.1
2.8
—
—
—
0
0
33
386
0.80
0.46
2.9
3.2
60.95
35.90
ng/l
0.35
20
247
7
51
1.39
0.45
6.4
11.0
24.14
23.62
mmol/l
—
7
51
26
214
1.27
0.44
2.0
1.8
—
—
—
0
0
12
87
1.42
0.44
1.8
3.4
4.99
4.74
kpa
0.11
12
87
8
57
1.43
0.43
1.1
2.7
0.48
0.63
%
—
8
57
5
34
1.49
0.41
1.8
1.2
462.20
142.17
u/ml
—
5
18
0
18
0.00
0.40
0.0
2.6
—
—
—
0
0
11
80
1.41
0.40
1.8
2.0
219.82
249.62
pmol/l
0.49
11
74
115
1174
0.72
0.39
27.5
22.1
41.93
41.93
%
0.00
115
1165
115
1174
0.72
0.39
27.0
21.7
91.04
90.88
fl
0.15
115
1166
115
1174
0.72
0.39
27.0
21.7
30.43
30.51
pg
0.19
115
1166
0
19
0.00
0.39
0.0
3.3
—
20.92
—
0
13
17
135
1.30
0.37
1.4
1.3
—
—
—
0
0
54
489
1.18
0.37
3.2
2.8
—
—
estimate
—
0
0
101
1048
0.80
0.35
4.1
4.3
1.47
1.37
mmol/l
0.51
95
998
21
249
0.81
0.33
4.1
3.2
1.02
1.02
kg/l
0.51
14
156
21
176
1.23
0.31
6.4
3.9
0.78
0.82
mmol/l
0.75
21
170
8
62
1.31
0.29
6.6
1.3
—
—
—
0
0
18
150
1.23
0.28
2.7
2.8
2.12
2.28
g/l
0.59
18
137
45
410
1.15
0.27
2.0
2.0
107.18
93.64
pmol/l
1.36
26
224
12
95
1.29
0.27
2.1
2.0
40.00
39.96
nmol/l
0.00
12
95
8
66
1.23
0.27
8.4
1.3
—
—
—
0
0
8
66
1.23
0.27
8.4
1.3
—
—
—
0
0
8
66
1.23
0.27
8.4
1.3
—
—
—
0
0
8
66
1.23
0.27
2.1
1.1
—
—
—
0
0
11
138
0.78
0.27
1.4
1.5
—
—
—
0
0
8
67
1.21
0.27
8.5
1.3
—
—
—
0
0
103
1058
0.84
0.23
20.3
13.9
24.11
23.48
mg/l
0.07
85
860
5
41
1.23
0.22
1.4
1.7
0.85
1.45
g/l
—
5
36
61
575
1.12
0.21
4.3
3.2
0.00
0.00
estimate
-0.00
13
107
0
11
0.00
0.21
0.0
4.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
71.18
—
0
11
0
10
0.00
0.21
0.0
2.8
—
106.60
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.8
—
1.16
—
0
10
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
3.5
—
44.10
—
0
10
0
10
0.00
0.21
0.0
2.8
—
3.90
—
0
10
62
585
1.12
0.21
4.3
3.3
0.00
0.00
estimate
-0.00
12
99
0
12
0.00
0.21
0.0
1.3
—
19.48
—
0
12
0
12
0.00
0.21
0.0
2.6
—
1778.33
—
0
12
0
13
0.00
0.21
0.0
10.1
—
977.62
—
0
13
35
320
1.13
0.20
2.3
2.3
249.94
208.22
u/l
0.19
35
303
31
340
0.88
0.20
1.4
1.5
—
—
—
0
0
13
153
0.83
0.19
1.3
1.4
—
—
—
0
0
30
329
0.88
0.19
2.1
2.6
0.66
0.71
ug/l
0.13
16
171
7
60
1.18
0.18
10.4
10.3
0.73
0.66
%
—
7
60
10
120
0.82
0.17
1.1
1.2
—
—
—
0
0
61
580
1.10
0.17
4.3
3.2
91.79
0.00
estimate
0.47
14
104
5
68
0.72
0.17
1.6
1.2
—
—
—
0
0
9
79
1.15
0.15
9.0
3.1
—
—
—
0
0
9
81
1.12
0.15
1.3
1.1
—
—
—
0
0
36
336
1.10
0.14
3.0
2.7
—
0.40
—
0
5
37
392
0.92
0.12
2.6
1.9
—
—
—
0
0
22
202
1.11
0.11
1.4
1.3
25.46
27.51
iu/ml
—
5
63
32
301
1.09
0.10
5.0
3.2
0.00
0.00
estimate
-0.00
12
103
5
45
1.12
0.10
1.6
1.2
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
0.69
—
0
9
5
64
0.77
0.08
1.0
1.1
1.40
1.45
g/l
—
5
64
7
63
1.12
0.08
10.4
10.0
1.13
1.65
%
—
7
63
7
64
1.10
0.08
2.1
4.3
4.79
4.59
pmol/l
—
7
58
22
232
0.94
0.05
3.0
1.9
0.89
1.55
mg/l
0.98
17
179
47
478
0.97
0.02
3.7
3.1
263.61
125.30
ug/l
0.66
47
465
11
104
1.06
0.01
8.4
8.8
7.40
7.42
ph
—
5
59
11
106
1.04
0.00
8.4
8.5
5.30
5.02
kpa
0.77
11
101
77
772
0.99
0.00
4.3
4.3
14.13
14.69
pmol/l
1.32
72
725
20
197
1.02
0.00
1.5
1.3
27.65
5.15
u/ml
0.78
12
86
29
287
1.01
0.00
7.0
5.3
—
—
—
0
0
46
455
1.02
0.00
13.8
11.2
1.18
1.17
inr
0.02
35
366
24
235
1.03
0.00
1.3
1.4
3.02
2.46
g/l
0.18
13
161
6
59
1.02
0.00
2.8
2.7
4.87
5.05
kpa
—
6
59
6
59
1.02
0.00
1.7
3.5
158.53
150.93
ng/l
—
6
52
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.00
—
0
5
7
70
1.00
-0.00
1.3
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
6
64
0.93
-0.00
1.0
1.1
1.08
0.91
g/l
—
6
64
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
1.07
—
0
5
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
9.28
—
0
5
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
8.22
—
0
9
6
69
0.86
-0.00
16.2
3.7
1.23
1.23
mmol/l
—
6
63
0
5
0.00
-0.00
0.0
1.6
—
6.08
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
1.86
—
0
5
0
6
0.00
-0.00
0.0
1.8
—
28.00
—
0
6
0
7
0.00
-0.00
0.0
1.6
—
3.29
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
84.50
—
0
6
8
88
0.90
-0.00
1.8
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
30.96
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
59.40
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
14.8
—
6.60
—
0
5
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_PEDICULOSIS_AND_PHTHIRIAASIS and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
AB1_PEDICULOSIS_AND_PHTHIRIAASIS 3.346 [2.54, 4.41] < 0.001
Birth year 0.988 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 328 males with AB1_PEDICULOSIS_AND_PHTHIRIAASIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_PEDICULOSIS_AND_PHTHIRIAASIS.

N-year risk Females Males
1 No data 0.722%
5 No data 4.328%
10 No data 10.4%
15 No data 18.78%
20 No data 30.318%

Relationships between endpoints

↥

Index endpoint: AB1_PEDICULOSIS_AND_PHTHIRIAASIS – Pediculosis and phthiriasis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data